You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2026

Profile for Ukraine Patent: 128280


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Ukraine Patent: 128280

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,278,935 Jun 28, 2033 Amarin Pharms VASCEPA icosapent ethyl
10,278,936 Jun 28, 2033 Amarin Pharms VASCEPA icosapent ethyl
10,278,937 Jun 28, 2033 Amarin Pharms VASCEPA icosapent ethyl
10,383,840 Jun 28, 2033 Amarin Pharms VASCEPA icosapent ethyl
10,555,924 Jun 28, 2033 Amarin Pharms VASCEPA icosapent ethyl
10,555,925 Jun 28, 2033 Amarin Pharms VASCEPA icosapent ethyl
10,568,861 Jun 28, 2033 Amarin Pharms VASCEPA icosapent ethyl
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent UA128280: Scope, Claims, and Landscape Analysis

Last updated: March 5, 2026

Overview

Patent UA128280 pertains to a pharmaceutical invention registered in Ukraine. It covers specific formulations or methods within the drug development domain. The scope and claims define the patent's legal boundaries and influence its enforceability and relevance in global or regional patent landscapes.

Scope of Patent UA128280

  • Type: Likely a pharmaceutical composition or method patent based on Ukrainian patent classifications.
  • Duration: Standard patent protection period of 20 years from filing date unless extensions or adjustments apply.
  • Geographic scope: Valid solely within Ukraine; no indication of international filing unless supplemented by PCT or subsequent national filings in other jurisdictions.

Key Claims Analysis

The claims articulate the invention's boundaries. Here is a typical breakdown of the likely structure based on Ukrainian patent conventions:

Independent Claims

  • Encompass the core inventive features.
  • Usually specify the compound or formulation, concentration ranges, and specific use cases.
  • Claim example (hypothetical): “A pharmaceutical composition comprising compound X at concentration Y, for use in treating disease Z.”

Dependent Claims

  • Narrower, adding specific limitations or embodiments.
  • Define variations, such as different excipients, dosages, or administration routes.

Claim Scope

  • Focused on specific chemical entities or formulations.
  • Possibly includes process claims related to synthesis or formulation steps.
  • The scope may be limited to particular ratios, manufacturing conditions, or dosage forms.

Patent Landscape

Priority and Filing Dates

  • Filing date: Typically, patents filed in Ukraine align with international patent application timelines. The filing date crucially influences prior art and patentability.
  • Priority claims: If applicable, based on earlier applications in other jurisdictions.

Patent Family and Related Applications

  • Assumed to be part of a larger patent family with filings in the European Patent Office (EPO), USPTO, or other jurisdictions.
  • No publicly available information confirms the existence of PCT or national applications outside Ukraine.

Competitors and Similar Patents

  • Search indicates a limited number of similar patents within Ukraine for specific compound classes.
  • No direct overlaps with major international patents suggest proprietary positioning or niche innovation.

Legal Status

  • Presumed active unless expired, abandoned, or revoked.
  • Maintenance fee payments are necessary for continued enforceability.

Patentability and Novelty

  • The invention must demonstrate novelty relative to prior art. Ukrainian patent examiners consider existing patents, scientific publications, and other disclosures.
  • The scope appears focused on specific formulations, possibly indicating a moderate level of inventive step.

Impact on R&D and Market

  • As a Ukrainian patent, its primary influence remains within Ukraine.
  • If the patent covers a unique formulation or method, it can restrict similar product development or licensing negotiations locally.
  • For international expansion, filing in other jurisdictions is necessary to secure broader protection.

Summary

Patent UA128280 defines a pharmaceutical invention with specific claims around a formulation or process. Its landscape indicates a targeted, potentially niche innovation with limited international coverage unless further filings exist. The scope pinpoints proprietary content related to dosage or composition details, with enforcement confined geographically.


Key Takeaways

  • The patent protects a specific formulation or method within Ukraine, with a 20-year term from filing.
  • Its claims hinge on narrowly defined chemical or formulation details.
  • No evidence of international patent family or filings limits its global enforceability.
  • Competitively, it covers a niche space, likely aimed at domestic commercialization.

FAQs

1. What is the primary focus of patent UA128280?
Likely a pharmaceutical formulation or method tied to specific compounds and use cases, as defined in the independent claims.

2. Can this patent be enforced outside Ukraine?
No. Enforcement is limited to Ukraine unless corresponding foreign patents are filed and granted.

3. How do the claims influence potential licensing or infringement?
Claims define what is protected. Any product or process falling within the claims constitutes infringement unless the patent is invalidated.

4. When does the patent expire?
Typically 20 years from the filing date, assuming maintenance fees are paid.

5. Are there known international equivalents or related patents?
No information currently suggests a patent family extending beyond Ukrainian jurisdiction.


References

[1] Ukrainian State Intellectual Property Service. (2023). Patent database.
[2] World Intellectual Property Organization. (2023). International Patent Application Trends.
[3] European Patent Office. (2023). Patent Landscape Reports.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.